OBIOOrchestra BioMed Holdings, ...

Nasdaq N/A


$ 4.73 $ -0.11 (-2.34 %)    

Monday, 13-May-2024 15:59:48 EDT
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 4.6
$ 4.81
$ 4.62 x 100
$ 0.00 x 0
$ 4.51 - $ 4.81
$ 4.22 - $ 20.19
25,405
na
164.58M
$ 0.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 01-25-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 orchestra-biomed-hldgs-q1-eps-038-beats-041-estimate-sales-62000k-miss-94000k-estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate o...

 chardan-capital-maintains-buy-on-orchestra-biomed-hldgs-maintains-20-price-target

Chardan Capital analyst Keay Nakae maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and maintains $20 price target.

 orchestra-biomed-hldgs-q4-eps-037-beats-038-estimate-sales-26200k-miss-99000k-estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate o...

Core News & Articles

New pharmacokinetic data demonstrate Virtue® SAB enables extended release of sirolimus above required tissue concentrations i...

 orchestra-biomed-announces-presentation-of-results-from-clinical-study-demonstrating-hemodynamic-effects-of-avim-therapy-in-hypertensive-pacemaker-patients

Clinical study evaluated impact of AVIM therapy as compared to standard pacing using invasive pressure-volume loop analysis in ...

Core News & Articles

8.9 mmHg mean reduction in 24-Hour ambulatory systolic blood pressure at average of 3.6 years from initiation of AVIM therapy...

 jefferies-initiates-coverage-on-orchestra-biomed-hldgs-with-buy-rating-announces-price-target-of-14

Jefferies analyst Matthew Taylor initiates coverage on Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy rating and announces ...

 orchestra-biomed-says-first-patient-was-randomized-in-the-backbeat-pivotal-study-in-late-december-2023

The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation therapy (also known as...

 orchestra-biomed-hldgs-q3-eps-038-up-from-051-yoy-sales-41900k-down-from-116m-yoy

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.38) per share. This is a 25.49 percent increase over loss...

 top-4-health-care-stocks-that-should-keep-you-up-at-night

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

 why-gorilla-technology-group-shares-are-trading-lower-by-25-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

 why-terran-orbital-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

 crude-oil-rises-over-1-revance-therapeutics-shares-plummet

U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday. The Dow traded do...

 orchestra-biomed-vital-farms-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower on Tuesday. Here are some big stocks recording gains in today’s session.

 why-clearmind-medicine-shares-are-trading-lower-by-53-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreeme...

 why-super-league-gaming-are-trading-lower-by-around-46-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION